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INTRODUCTION
Cutis laxa (CL) is a skin disorder
characterized by prematurely redundant,
pendulous, inelastic, and wrinkled skin
(Berk et al., 2012), and is associated with
variable involvement of other organs.
Both acquired and inherited forms of CL
exist and the latter show extensive locus
heterogeneity and congenital onset. The
main histopathologic and ultrastructural
anomalies in the skin of patients with
CL are paucity, fragmentation, or dis-
organization of the dermal elastic fibers
(Figure 1a). Studies of inherited forms of
CL have uncovered a growing network
of genes (Table 1). On the basis of
congenital nature of most inherited
forms of CL, these genes are necessary
for elastic fiber biogenesis and are
distinct from genes involved in the
homeostatic maintenance such as those
inhibiting ectopic calcification of the
elastic fibers (Li and Uitto, 2012).
ELASTIC FIBER NETWORK
The elastic fibers consist of microfibrils,
elastin, and associated proteins, and
show tissue-specific organization
(Kielty, 2006). In the skin, they are
organized in horizontally undulating
deep dermal elastic fibers (Figure 1b,
arrowhead), connected to thinner, ver-
tical elaunin fibers, which show a
candelabra-like branching pattern to-
ward the dermal–epidermal junction
(Figure 1b, arrow). The elaunin fibers
further branch and terminate in oxyta-
lan fibers, which are composed mostly
of microfibrils and anchor the network
to the dermal side of the basement
membrane. The skin phenotype of pa-
tients with CL suggests that the elastic
fiber system is not required for the
anchoring of the epidermis to the dermis
(which is disrupted in blistering diseases)
(Bruckner-Tuderman and Has, 2012), but
rather appears to couple the growth of
the skin to the rest of the body.
MOLECULAR BASIS OF CL
Studies on X-linked CL provided the
first insight in to the molecular basis
of this disease by showing reduced
activity of lysyl oxidase, an enzyme
required of the cross-linking of both
Figure 1. Elastic fiber abnormalities in cutis laxa. Hart’s elastin stain of a skin biopsy specimen from
(a) a patient with ARCL1C/URDS caused by a homozygous mutation in LTBP4, and from (b) a normal
control individual. Deep dermal elastic fibers (arrowhead) are diminished and show altered staining in
the patient. The elastic fibers in the superficial dermis are missing in the patient but are present in the
normal control (arrow). Magnification bars: 20 mm. Reproduced from (Urban et al., 2009).
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elastin and collagens (Byers et al.,
1980) (Byers and Murray, 2012).
X-linked CL was recognized to be
identical to occipital horn syndrome,
found to be allelic to Menkes disease,
and to be caused by mutations in the
copper transporter ATP7A (Kaler et al.,
1994). The activity of lysyl oxidase
and several other enzymes (tyrosinase,
dopamine b-hydroxylase) is dependent
on copper.
Genes encoding known components
of the elastic fibers became candidate
genes for CL. First, mutations in the elastin
gene (ELN) were identified in autosomal
dominant CL (ADCL) (Tassabehji et al.,
1998; Zhang et al., 1999), characterized
by a relatively mild course, but sometimes
associated with aortic aneurysm and pul-
monary emphysema (Urban et al., 2005;
Szabo et al., 2006). The ELN mutations
responsible for ADCL result in a protein
deficient in interacting with micro-
fibrils but with increased self-association
(Callewaert et al., 2011). Incorporation of
mutant elastin into the elastic fibers results
in reduced compliance of tissues (Hu
et al., 2010), consistent with a dominant-
negative mechanism.
Autosomal recessive CL type 1
(ARCL1) is a disease with high infantile
and childhood mortality because of
severe developmental emphysema or
vascular defects. The identification
of all three genes responsible for ARCL1
was greatly aided by the similarity in
phenotype to knockout mouse models.
ARCL1A associated with arterial tor-
tuosity, aneurysms, and bone fragility
is caused by mutations in fibulin-4
(FBLN4/EFEMP2) (Hucthagowder et al.,
2006). ARCL1B is distinguished by the
presence of supravalvular aortic stenosis,
and fibulin-5 (FBLN5) is mutated in
affected individuals (Loeys et al., 2002).
Finally, ARCL1C, a disease with severe
gastrointestinal and urinary involvement,
is a result of mutations in the gene for
the latent transforming growth factor-
beta-binding protein 4 (LTBP4) (Urban
et al., 2009).
All the three genes for ARCL1
(FBLN4, FBLN5, LTBP4) encode secre-
ted, multi-adhesive proteins required
for the hierarchical, cell-directed pro-
cess of elastic fiber assembly (Czirok
et al., 2006). Transforming growth
factor-beta (TGFb) signaling is a com-
mon downstream pathway activated
in ADCL (Hu et al., 2010; Callewaert
et al., 2011), ARCL1A (Renard et al.,
2010), and ARCL1C (Urban et al.,
2009), and may provide a useful
therapeutic target in the future.
ARCL type 2 (ARCL2) and related
syndromes are associated with growth
and developmental delay. Positional
cloning of several causative genes
has uncovered intracellular molecular
pathways previously not connected to
elastic fiber biogenesis. ARCL2A, char-
acterized by abnormal glycosylation of
serum proteins, is a result of mutations
in the ATP6V0A2 gene, encoding the
A2 subunit of the vesicular proton
pump (Kornak et al., 2008).
Patients with ARCL2B have trian-
gular face and prematurely aged
appearance and carry mutations in
the pyrroline-5-carboxylate reductase
(PYCR1) gene, encoding a mitochon-
drial enzyme involved in the proline
biosynthetic pathway (Guernsey et al.,
2009). Mutations in this gene result in
altered mitochondrial morphology and
increased oxidative stress (Reversade
et al., 2009).
De Barsy syndrome is an autosomal
recessive disease overlapping with the
ARCL2 phenotype, but distinguished
by the presence of corneal opa-
cities and cataracts. Mutations in
ATP6V0A2 (Kornak et al., 2008),
PYCR1 (Reversade et al., 2009), or
the gene for D1-pyrroline-5-carboxylate
synthase (ALDH18A1) (Skidmore et al.,
2011), encoding another mitochon-
drial proline biosynthetic enzyme,
have been described in patients with
De Barsy syndrome.
Gerodermia osteodysplastica is a rela-
ted disease characterized by marked
bone fragility and caused by reces-
sive mutations in the GORAB gene
(Hennies et al., 2008), which encodes a
binding partner of the Rab6 guanosine
triphosphatase involved in vesicular
trafficking. Finally, CL with macro-
cephaly, alopecia, and scoliosis is a
recessive disease linked to mutations
in the RIN2 gene (Basel-Vanagaite
et al., 2009), encoding a interactor of
the Rab5 guanosine triphosphatase,
another small G protein required for
vesicle sorting and trafficking.
These gene identification studies
have highlighted the essential role of
the secretory pathway in elastic fiber
biogenesis. For example, the secretion
of the elastin precursor, tropoelastin,
Table 1. Genes for cutis laxa and related conditions
Disease Distinguishing clinical features Mutated genes
ADCL Pulmonary and cardiovascular manifestations absent,
milder or later onset
ELN
ARCL1A Arterial tortuosity, lethal pulmonary hypertension,
bone fragility
FBLN4/EFEMP2
ARCL1B Supravalvular aortic stenosis, lethal developmental
emphysema
FBLN5
ARCL1C/URDS Severe gastrointestinal and urinary malformations,
lethal developmental emphysema mild cardiovascular
involvement
LTBP4
ARCL2A Growth and developmental delay, abnormal
glycosylation of serum proteins
ATP6V0A2
ARCL2B Growth and developmental delay, triangular face,
normal glycosylation
PYCR1
XLCL Occipital exostoses, pili torti ATP7A
DBS/ARCL3 Corneal clouding, athetoid movements ATP6V0A2, PYCR1,
ALDH18A1
GO Bone fragility, short stature GORAB
MACS Macrocephaly, alopecia, scoliosis RIN2
Abbreviations: ADCL, autosomal dominant cutis laxa; ARCL, autosomal recessive cutis laxa;
ATS, arterial tortuosity syndrome; DBS, DeBarsy syndrome; GO, geroderma osteodysplastica;
MACS, macrocephaly-alopecia-cutis laxa-scoliosis syndrome; URDS, Urban–Rifkin–Davis syndrome;
XLCL, X-linked cutis laxa.
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is impaired in cells with ATP6V0A2
mutations leading to accumulation
of tropoelastin in Golgi vesicles
(Hucthagowder et al., 2009). Conver-
sely, in cells with RIN2 mutations the
production of microfibrils and fibulin-5
appears to be disrupted (Basel-
Vanagaite et al., 2009). These discov-
eries support the emerging notion that
appropriate intracellular sorting and
routing of individual elastic fiber pro-
teins, or groups of proteins are essential
for normal extracellular fiber assembly.
Whether preassembly (or micro-
assembly) of these components occurs
in particular secretory compartments
will be an interesting question to
address.
Another surprising set of molecules
implicated in elastogenesis are mitochon-
drial enzymes of the proline biosynthesis
pathway. Both elastin and collagens
are proline-rich proteins, and thus their
synthesis may be particularly sensitive to
the availability of this amino acid. How-
ever, not all disease-causing ALDH18A1
mutations affect the flux through the
proline biosynthetic pathway (Bicknell
et al., 2008), suggesting that this enzyme,
and by extension possibly PYCR1 as well,
may have another function more relevant
to the disease mechanism. Discovery of
howmitochondrial and secretory proteins
orchestrate an intracellular milieu con-
ducive to elastic fiber assembly in the
extracellular space will open up exciting
novel areas of research and new avenues
for interventions to treat disorders of the
elastic fiber system.
CONCLUSIONS
The phenotypes and associated mole-
cular defects in CL highlight the inte-
gration of molecular networks required
for elastic fiber biogenesis with path-
ways associated with other structural
skin disorders. Several forms of CL
show joint laxity, a hallmark of Ehlers–-
Danlos syndrome (Byers and Murray,
2012), and RIN2 mutations result in a
phenotype that appears to be inter-
mediate between CL and Ehlers–Danlos
syndrome (Syx et al., 2010). Sparse hair
has been described in several CL syn-
dromes including patients with ELN
mutations (Szabo et al., 2006). More-
over, RIN2 mutations result in alopecia
(Basel-Vanagaite et al., 2009). Thus,
the elastic fiber system may be
connected to the molecular network
disrupted in structural hair disorders
(Harel and Christiano, 2012).
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